In the BioHarmony Drug Report Database

"Preview" Icon

Liothyronine

Cytomel, Triostat (liothyronine) is a small molecule pharmaceutical. Liothyronine was first approved as Cytomel on 1982-01-01. It is used to treat autoimmune thyroiditis, goiter, myxedema, thyroid neoplasms, and thyrotoxicosis in the USA. The pharmaceutical is active against thyroid hormone receptor beta and thyroid hormone receptor alpha.

 

Trade Name

 

Cytomel, Triostat
 

Common Name

 

liothyronine
 

ChEMBL ID

 

CHEMBL1544
 

Indication

 

autoimmune thyroiditis, goiter, myxedema, thyroid neoplasms, thyrotoxicosis
 

Drug Class

 

Image (chem structure or protein)

Liothyronine structure rendering